Pediculosis and phthiriasis, including avohilmo

AB1_PEDICULOSIS_AND_PHTHIRIAASIS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — B85 Hospital discharge: ICD-10 — B85 Hospital discharge: ICD-9 — 13[2-3] Hospital discharge: ICD-8 — 13[2-3] Hospital discharge: excluded ICD-9 — 1330A Hospital discharge: excluded ICD-8 — 13[3-4]0 Cause of death: ICD-10 — B85 Cause of death: ICD-9 — 13[2-3] Cause of death: ICD-8 — 13[2-3] Cause of death: excluded ICD-9 — 1330A Cause of death: excluded ICD-8 — 13[3-4]0 3 out of 7 registries used, show all original rules.	287
4. Check minimum number of events None	287
5. Include endpoints None	287
6. Filter based on genotype QC (FinnGen only)	247

Control definitions (FinnGen only)

Control exclude: AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_PEDICULOSIS_AND_PHTHIRIAASIS_WIDE
CONTROL_EXCLUDE	AB1_PEDICULOSIS_ACARIASIS_OTHERINFEST
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	B85
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B85
HD_ICD_9	13[2-3]
HD_ICD_8	13[2-3]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	1330A
HD_ICD_8_EXCL	13[3-4]0
COD_MAINONLY
COD_ICD_10	B85
COD_ICD_9	13[2-3]
COD_ICD_8	13[2-3]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1330A
COD_ICD_8_EXCL	13[3-4]0
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pediculosis and phthiriasis, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Pediculosis and phthiriasis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	247	145	102
Unadjusted period prevalence (%)	0.05	0.05	0.05
Median age at first event (years)	34.95	39.25	28.83

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
270: Matched controls
2700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B85.0

ICD-10 Finland

Pediculosis due to Pediculus humanus capitis

+∞

166.4

142

B85.3

ICD-10 Finland

Phthiriasis

+∞

49.5

1322A

ICD-9 Finland

Pediculosis and phthirus infestation, Phthirus pubis [pubic louse]

+∞

21.1

13299

ICD-8 Finland

Pediculosis

+∞

19.0

S73

ICPC

Pediculosis/skin infestation other

56.6

18.2

P02CF01

ATC

ivermectin; oral

101.8

17.8

B85.2

ICD-10 Finland

Pediculosis, unspecified

+∞

11.5

L29

ICD-10 Finland

Pruritus

12.9

10.0

B85

ICD-10 Finland

Pediculosis and phthiriasis

+∞

9.4

N76.0

ICD-10 Finland

Acute vaginitis

3.2

9.4

144

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

9.0

369

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

3.2

8.3

120

M54

ICD-10 Finland

Dorsalgia

2.5

7.4

235

Z71.8

ICD-10 Finland

Other specified counselling

2.0

7.1

117

744

R07.0

ICD-10 Finland

Pain in throat

2.9

6.6

119

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.7

6.3

13399

ICD-8 Finland

Acariasis, Other

+∞

6.3

B86

ICD-10 Finland

Scabies

5.6

6.3

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

9.50

5.84

2.3

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

112

787

1.72

4.45

3.6

2.2

—

(3018095) Leukocytes [#/volume] in Urine

116

849

1.64

3.81

4.3

4.0

58.06

83.18

e6/l

0.17

568

(3028707) Methadone [Presence] in Urine by Screen method

2.65

3.72

6.8

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

537

1.70

3.64

3.5

1.9

—

(3000494) Fungus identified in Specimen by Culture

288

1.86

3.49

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

599

1.64

3.36

3.5

3.1

0.13

0.34

e6/l

2.16

441

(3002582) Erythrocytes [#/volume] in Urine

696

1.59

3.16

3.5

3.2

12.04

46.21

e6/l

2.41

529

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

197

1685

1.63

3.12

8.1

73.08

78.02

u/l

1.40

182

1602

(3011288) Drugs identified in Urine by Screen method Nominal

122

2.16

2.98

7.5

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

578

1.57

2.81

4.1

2.4

—

(3016879) Cocaine [Presence] in Urine

169

1.94

2.77

4.5

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

528

1.58

2.75

3.9

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

145

1179

1.50

2.71

6.2

6.6

12.42

13.07

umol/l

0.13

136

1122

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

287

1.73

2.68

4.9

2.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

562

1.55

2.57

1.7

1.5

21.71

20.23

nmol/l

0.42

487

(3022145) Colonoscopy Study observation

251

1.75

2.56

1.4

—

(3002032) Base excess in Venous blood by calculation

221

1.78

2.51

2.6

4.8

2.78

1.62

mmol/l

0.64

185

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.89

2.48

2.4

1.3

—

(3027008) Opiates [Presence] in Urine

177

1.85

2.43

5.0

1.5

—

(3000991) Gas panel - Venous blood

201

1.79

2.39

4.8

9.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

414

1.58

2.37

2.7

1.7

—

(3028300) Cannabinoids [Presence] in Urine

179

1.83

2.35

5.3

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

391

1.58

2.31

1.9

1.59

1.38

1.47

351

(3000850) Epithelial cells [#/volume] in Urine

477

1.54

2.31

3.1

2.6

6.68

7.65

e6/l

0.16

430

(40768443) Skin Pathology biopsy report

100

2.08

2.27

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

126

1023

1.43

2.24

2.5

2.7

69.22

72.84

nmol/l

0.89

115

940

(1761868) Lipid panel - Serum or Plasma

1056

0.68

2.23

3.2

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

344

1.59

2.22

5.2

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

662

1.46

2.17

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

450

1.52

2.13

1.4

1.3

16.37

7.91

u/ml

0.55

186

(3000764) Benzodiazepines [Presence] in Urine

177

1.78

2.13

5.2

1.5

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

235

2163

1.67

2.12

14.8

12.3

92.80

90.80

ml/min/173m2

0.78

211

1949

(3037121) Protein [Mass/volume] in Urine

2.10

2.11

2.9

5.1

126.33

404.58

mg/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

675

1.45

2.09

1.9

1.8

—

(42870588) Differential panel, method unspecified - Blood

102

808

1.42

2.03

6.1

6.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

165

1.78

2.00

1.2

1.4

—

(3027944) Amphetamines [Presence] in Urine

181

1.74

1.98

5.4

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

721

1.42

1.93

3.6

3.1

2.35

mmol/l

0.02

659

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

112

909

1.40

1.92

2.2

1.9

98.03

95.47

pmol/l

0.26

483

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

231

1.64

1.91

3.3

2.5

23.03

29.40

u/l

2.39

194

(3013826) Glucose [Moles/volume] in Serum or Plasma

154

1322

1.38

1.86

5.1

6.39

6.46

mmol/l

0.15

140

1220

(44806420) Estimation of glomerular filtration rate

3.10

1.81

2.1

1.7

—

(3012544) pH of Venous blood

228

1.61

1.76

2.6

4.7

7.37

7.38

0.21

145

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.19

1.74

1.1

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

2.72

1.74

3.0

2.2

16.70

16.60

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.90

1.72

1.2

1.3

—

(3018010) Neutrophils/Leukocytes in Blood

138

1174

1.36

1.72

5.5

6.4

55.96

56.63

0.27

125

1137

(1001926) Buprenorphine [Presence] in Urine by Screen method

143

1.74

1.67

6.8

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

490

1.43

1.67

1.4

1.3

19.49

28.09

iu/ml

0.53

146

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2.85

1.66

2.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

199

1.63

1.66

2.9

2.2

11291.52

9272.97

u/l

0.10

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2.54

1.61

2.4

1.6

—

(4198724) Urine methamphetamine measurement

3.04

1.59

6.8

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

285

1.52

1.58

4.6

3.3

4.97

6.95

umol/l

0.99

248

(3024561) Albumin [Mass/volume] in Serum or Plasma

108

896

1.34

1.54

5.4

5.5

35.16

36.85

g/l

2.26

102

856

(3006504) Eosinophils/Leukocytes in Blood

134

1149

1.33

1.53

5.9

6.6

2.80

2.76

0.07

120

1096

(3026008) Bacteria identified in Urine by Culture

609

1.37

1.49

2.6

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

214

1.56

1.46

6.7

6.5

—

(3019069) Monocytes/Leukocytes in Blood

134

1154

1.32

1.46

6.0

6.6

8.13

8.53

1.10

120

1107

(3015736) pH of Urine

126

1077

1.32

1.44

4.0

3.2

6.31

6.20

0.43

624

(3022096) Basophils/Leukocytes in Blood

133

1147

1.31

1.43

6.0

6.6

0.68

0.05

118

1090

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

361

1.44

1.42

3.3

2.5

2.43

mmol/l

0.05

324

(3007853) Bacteria identified in Skin by Aerobe culture

292

1.48

1.41

1.9

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

275

1.49

1.41

5.0

7.6

102.82

104.39

mmol/l

0.98

275

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

560

1.36

1.39

2.4

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

276

1.48

1.39

1.6

—

(3011648) Oxygen content in Venous blood

2.64

1.37

1.2

3.4

10.43

11.99

—

(3044640) Blood type and Crossmatch panel - Blood

767

1.32

1.36

2.7

2.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

153

1.62

1.34

2.3

2.2

68.11

75.35

ml/min/173m2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

536

1.36

1.34

2.3

2.1

0.75

1.27

mg/l

1.78

405

(3004616) Nuclear Ab [Presence] in Serum

2.53

1.31

1.5

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.93

1.31

2.2

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.93

1.31

2.4

1.7

0.82

0.38

nmol/l

0.31

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.98

1.30

1.2

—

(3013115) Eosinophils [#/volume] in Blood

148

1307

1.29

6.1

6.7

0.19

e9/l

0.10

121

1153

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

333

1.42

1.28

2.2

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.08

1.28

1.4

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

247

1.48

1.27

2.3

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

100

1.75

1.26

1.6

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

155

1379

1.29

1.26

8.3

9.9

4.06

4.05

e9/l

0.01

131

1213

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.26

1.25

1.3

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.43

1.25

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

201

1.50

1.16

5.0

3.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

349

1.38

1.15

2.7

3.0

4.15

2.27

e6/l

0.60

177

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.93

1.14

1.1

1.2

—

1.03

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

377

1.37

1.12

2.7

2.9

2.70

0.82

e6/l

0.59

205

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.29

1.11

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

570

1.31

1.10

2.3

2.1

2.37

2.78

mg/l

1.16

503

(3001604) Monocytes [#/volume] in Blood

141

1254

1.26

1.10

6.1

6.6

0.53

0.57

e9/l

1.00

117

1092

(3035715) Granulocytes [#/volume] in Blood

1.98

1.09

4.5

3.9

3.49

4.24

e9/l

—

(40768800) Prostate Pathology biopsy report

2.41

1.09

1.6

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.90

1.09

1.5

1.3

—

(3026782) Osmolality of Urine

418

1.33

1.04

3.5

2.6

546.24

537.17

mosm/kgh2o

0.08

364

(3002030) Lymphocytes/Leukocytes in Blood

134

1190

1.25

1.04

6.0

6.5

29.30

29.09

0.08

124

1150

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.30

1.04

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

320

1.37

1.03

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

127

1122

1.25

1.03

2.9

2.8

—

estimate

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

107

1.63

1.02

1.2

3.3

0.51

0.60

0.83

107

(3021601) Nitrite [Presence] in Urine by Test strip

145

1301

1.25

1.02

4.3

3.4

0.00

estimate

-0.00

262

(3009261) Glucose [Presence] in Urine by Test strip

147

1322

1.25

1.01

4.3

3.5

0.00

estimate

-0.00

250

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

197

1834

1.27

0.99

5.5

4.6

14.25

14.56

pmol/l

1.08

182

1720

(3027315) Oxygen [Partial pressure] in Blood

1.97

0.97

3.7

2.6

9.53

9.25

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.97

0.97

3.7

2.6

5.04

5.03

kpa

—

(3006315) Basophils [#/volume] in Blood

140

1257

1.24

0.96

6.2

6.6

0.04

e9/l

0.28

117

1091

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

236

1.40

0.95

2.3

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

168

1.47

0.93

4.9

9.4

25.75

24.64

mmol/l

0.49

168

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.78

0.91

2.0

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.68

0.89

2.1

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.93

0.89

2.4

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.93

0.89

1.3

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

145

1314

1.22

0.89

4.3

3.4

36.71

12.00

estimate

0.29

261

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.89

0.88

1.5

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

142

1285

1.22

0.88

6.2

6.5

2.04

1.96

e9/l

0.31

120

1144

(21494815) CD4 cells/Lymphocytes in Specimen

2.02

0.87

2.5

2.0

28.53

41.27

—

(3026493) Urate [Moles/volume] in Serum or Plasma

579

1.26

0.86

3.4

2.9

330.28

331.81

umol/l

0.05

528

(3018418) pH of Serum or Plasma

610

1.25

0.83

4.6

4.3

7.39

7.40

0.23

424

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

197

1851

1.24

0.81

3.9

3.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

279

1.33

0.81

1.7

1.6

1382.09

1172.18

nmol/l

0.69

219

(3010421) pH of Blood

1.75

0.80

3.6

2.7

7.42

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.69

0.80

2.0

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

728

1.22

0.78

4.3

3.4

8.51

8.65

mmol/l

0.08

639

(3021901) Oxygen saturation in Capillary blood

1.78

0.77

3.5

4.0

94.67

91.17

—

(40758558) Short blood count panel - Blood

720

1.22

0.76

5.5

6.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

243

2347

1.35

0.75

16.4

13.6

20.79

21.69

mg/l

0.19

202

1906

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

703

1.22

0.74

2.9

2.8

52.74

56.33

u/l

0.60

662

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

143

1.43

0.72

1.7

1.6

—

(3032080) INR in Blood by Coagulation assay

879

1.20

0.72

12.6

9.5

1.14

1.15

inr

0.09

716

(3023520) Reticulocytes [#/volume] in Blood

152

1.41

0.71

2.8

2.5

65.28

75.84

e9/l

1.39

103

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.94

0.71

1.2

56.00

37.81

nmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

470

1.24

0.70

2.7

3.2

983.64

898.91

ng/l

0.10

391

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

349

0.75

0.70

2.0

3.43

3.56

ratio

0.22

278

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

304

1.29

0.70

1.6

852.91

941.68

mu/l

0.26

257

(3035933) Granulocytes/Leukocytes in Blood

1.66

0.69

4.4

3.2

56.55

57.00

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

153

1.40

0.69

1.9

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

154

1.39

0.67

2.6

1.5

0.57

0.33

mg/l

0.71

(3021589) Normoblasts [#/volume] in Blood

123

1121

1.18

0.65

10.8

10.4

0.00

e9/l

0.98

909

(3019550) Sodium [Moles/volume] in Serum or Plasma

237

2290

1.29

0.65

16.8

14.4

139.07

139.58

mmol/l

2.88

231

2248

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1.74

0.64

1.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.74

0.64

1.0

1.1

—

3.73

—

(3022621) pH of Urine by Test strip

187

0.68

0.63

1.5

2.0

6.36

6.20

—

109

(3023103) Potassium [Moles/volume] in Serum or Plasma

237

2292

1.28

0.63

17.0

14.6

3.95

3.94

mmol/l

0.10

231

2241

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.48

0.63

2.7

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

2.7

—

2.74

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.60

0.0

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

692

1.18

0.56

5.0

3.4

0.00

estimate

0.50

250

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

122

0.65

0.56

1.0

1.1

1.51

g/l

—

122

(3025941) Bacteria identified in Stool by Culture

151

1.35

0.56

1.6

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

361

1.23

0.55

1.3

1.4

340.00

389.59

titre

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

125

1.38

0.55

1.2

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

270

1.25

0.53

1.9

2.6

12.95

14.31

nmol/l

0.38

257

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

100

1.42

0.53

1.6

2.0

206.21

236.14

pmol/l

0.53

(3049717) Cytology report of Urine Cyto stain

1.44

0.53

1.4

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1.49

0.51

1.0

1.2

8.81

0.64

u/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

220

2270

0.83

0.51

5.2

5.1

2.79

mmol/l

0.00

203

2152

(40768797) Stomach Pathology biopsy report

290

1.24

0.51

1.5

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

215

2071

1.19

0.51

5.8

5.5

37.84

38.28

mmol/mol

0.30

199

1972

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

145

1.33

0.50

2.1

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

110

1.39

0.50

1.7

1.6

77.52

53.36

ug/l

0.84

110

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.47

0.49

1.6

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.50

0.48

1.1

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.50

0.48

1.1

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.49

0.47

1.3

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

147

1.31

0.46

1.4

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

110

1016

1.14

0.46

6.5

7.8

1.21

mmol/l

0.15

887

(3045424) Erythrocytes [Presence] in Urine

112

1.36

0.45

1.6

1.9

0.00

estimate

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

229

0.77

0.44

1.3

276.40

121.31

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

203

1.26

0.44

1.6

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

122

1.33

0.43

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

1.57

0.42

1.2

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

1.57

0.42

1.2

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

1.57

0.42

1.2

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

1.57

0.42

1.2

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1.41

0.41

1.0

1.2

2.37

1.58

u/ml

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.41

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.2

—

(3023368) Bacteria identified in Blood by Culture

545

1.15

0.41

6.1

4.2

—

(21494434) Karyotype in Bone marrow

0.00

0.41

0.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

219

2250

0.86

0.40

4.5

4.7

4.63

4.68

mmol/l

0.33

204

2142

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

691

1.14

0.40

1.2

1.4

1.40

1.82

u/ml

0.18

184

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

222

2157

1.16

0.39

6.3

5.3

1.71

1.79

mu/l

0.62

211

2040

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1.44

0.39

3.0

4.1

3.08

5.69

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

221

2147

1.16

0.39

4.7

4.3

5.82

5.83

mmol/l

0.04

204

2017

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

385

1.17

0.38

1.8

1.6

479.26

34111233.33

pmol/l

0.50

343

(1002224) Polysomnography panel

161

1.26

0.38

1.3

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

181

1738

1.13

0.38

4.1

4.0

8.54

9.22

mm/h

0.45

167

1633

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

114

0.69

0.38

2.1

44.75

40.00

u/l

—

105

(3017732) Neutrophils [#/volume] in Blood

320

1.18

0.37

1.8

2.9

9.64

7.60

e9/l

0.14

292

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

473

1.15

0.36

1.6

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

0.65

0.36

1.0

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

117

1.30

0.36

7.3

11.3

0.69

0.66

0.10

117

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

125

0.71

0.36

1.0

1.2

1.04

0.88

g/l

—

125

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

249

2446

1.23

0.36

12.2

10.9

27.52

27.53

u/l

0.00

244

2394

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

181

1.23

0.36

6.1

3.1

—

(3014051) Protein [Presence] in Urine by Test strip

755

1.12

0.35

2.8

—

0.29

—

(3003694) ABO and Rh group [Type] in Blood

844

1.12

0.35

1.8

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

854

1.12

0.35

4.8

3.6

30.15

31.10

u/l

0.12

820

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.33

0.34

1.0

1.2

11.13

2.75

u/ml

—

(40768804) Tissue Pathology biopsy report

894

1.11

0.34

2.1

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

763

0.89

0.34

3.6

2.7

0.00

0.02

estimate

0.68

212

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

758

1.12

0.33

3.7

3.2

41.37

29.69

ng/l

0.32

441

(21494755) Public health laboratory ask at order entry panel

347

0.85

0.33

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.28

0.32

2.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.32

0.32

5.7

5.2

1.52

1.23

mg/l

0.74

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

219

2241

0.88

0.32

4.5

4.6

1.39

1.43

mmol/l

0.94

199

2123

(3000492) Spirometry study

297

1.17

0.31

1.4

—

(4024509) Urine culture

0.70

0.31

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

121

1.25

0.29

7.3

11.1

1.63

1.44

0.26

121

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.29

0.28

1.2

1.3

—

(3025130) Human papilloma virus identified in Specimen

1.20

0.26

2.4

1.8

—

(3019150) Specific gravity of Urine by Refractometry

572

1.11

0.26

4.6

3.3

1.02

kg/l

0.38

380

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

123

1.23

0.26

2.0

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.24

0.25

1.8

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.26

0.25

2.1

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.17

0.24

1.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

381

1.12

0.24

2.9

2.4

236.70

100.02

ug/g

0.63

301

(3023511) Choriogonadotropin [Units/volume] in Urine

115

1.23

0.24

1.9

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

106

1.24

0.23

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

1.11

0.23

1.9

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.76

0.23

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.25

0.22

5.4

2.5

10.92

7.74

pmol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

116

1.22

0.22

1.2

2.4

15.11

25.96

u/ml

1.84

111

(36660697) Celiac disease serology panel - Serum

258

1.14

0.22

1.1

1.2

—

(1616796) Gas panel - Central venous blood

1.19

0.21

4.6

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

101

0.79

0.21

1.0

3.1

—

(3045414) Leukocytes [Presence] in Urine

211

1.15

0.21

1.7

1.8

0.00

estimate

—

(3006462) Nitrate [Presence] in Urine

0.00

0.21

0.0

4.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.21

0.0

1.0

—

0.65

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.21

0.0

7.6

—

7.80

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.7

—

34.00

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

7.08

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.21

0.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

83.98

—

(4211845) Urine protein measurement

0.00

0.21

0.0

4.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

0.43

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

15.21

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

3.2

—

0.92

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

1.8

—

108.99

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

211

2148

0.92

0.19

3.8

3.9

1.36

1.29

mmol/l

0.53

189

2027

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.14

0.19

1.0

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

268

0.89

0.18

1.7

1.8

3.61

3.49

mmol/l

0.17

191

(3001122) Ferritin [Mass/volume] in Serum or Plasma

132

1277

1.07

0.18

3.8

3.2

141.75

90.59

ug/l

0.61

122

1230

(3020682) Albumin/Creatinine [Ratio] in Urine

627

0.92

0.18

4.7

4.1

15.32

9.38

mg/mmol

0.22

412

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.17

0.18

2.1

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.13

0.17

2.1

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.23

0.17

1.6

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.11

0.17

1.1

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.15

0.16

1.9

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.16

0.15

1.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.13

0.15

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.19

0.14

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

112

1.17

0.14

2.1

3.1

137.71

130.73

ng/l

0.04

101

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

393

1.08

0.14

3.8

3.5

427.00

292.99

ng/l

0.24

258

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

407

0.92

0.14

2.2

2.6

0.66

0.69

ug/l

0.09

208

(3019060) Gas panel - Arterial blood

0.81

0.14

4.9

4.4

—

(3019977) pH of Arterial blood

199

1.11

0.14

6.2

9.0

7.41

7.42

0.33

112

(3001019) Free T4 and TSH panel - Serum or Plasma

180

1.12

0.13

1.4

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

161

1.13

0.13

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

337

1.08

0.12

2.5

1.9

—

(3012516) Albumin [Mass/volume] in Urine

617

0.94

0.12

3.6

3.5

81.51

75.10

mg/l

0.04

418

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

105

1.15

0.11

6.4

9.0

16.47

16.28

0.07

100

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

163

1.11

0.11

1.5

1.35

1.17

ratio

—

105

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

163

1.11

0.11

1.5

1.04

1.14

ratio

—

105

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

163

1.11

0.11

1.5

0.91

0.95

ratio

—

105

(3027801) Oxygen [Partial pressure] in Arterial blood

202

1.10

0.11

6.2

8.8

12.59

12.95

kpa

0.10

194

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

202

1.10

0.11

6.2

8.8

5.45

5.06

kpa

1.52

193

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

998

0.96

0.10

4.3

3.1

0.00

0.02

estimate

0.68

222

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

125

0.87

0.10

1.3

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.14

0.10

2.2

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

174

1.10

0.09

6.7

9.7

123.74

121.31

g/l

0.18

169

(3043409) Potassium [Moles/volume] in Arterial blood

1.09

0.09

6.4

4.2

4.14

3.90

mmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.09

0.09

5.4

5.2

—

1201.60

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.04

0.09

1.6

1.3

—

(40761511) CBC panel - Blood by Automated count

247

2453

1.08

0.09

13.8

11.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

628

1.05

0.09

1.2

1.4

2.40

2.28

g/l

0.08

402

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

175

0.91

0.09

1.6

67.78

62.56

ug/l

—

151

(3043238) Trisomy 21 risk [Likelihood] in Fetus

136

1.11

0.08

1.6

—

(40768793) Breast Pathology biopsy report

0.83

0.08

1.4

1.3

—

(4034850) Laboratory test

0.76

0.08

15.6

9.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.84

0.07

1.8

4.0

11.00

2768.69

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

0.85

0.07

1.7

1.4

401.67

180.77

u/ml

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.02

0.07

1.2

1.4

—

(4035726) Immunohistochemistry procedure

177

1.08

0.07

1.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

138

1.09

0.06

6.7

5.5

1.91

1.09

mmol/l

—

103

(3008152) Bicarbonate [Moles/volume] in Arterial blood

104

0.86

0.06

5.6

7.3

26.77

24.28

mmol/l

—

(3002256) Pathology report gross observation

272

0.95

0.05

1.2

—

(3005033) Fetal Nuchal fold Thickness US

130

1.08

0.04

1.6

1.5

1.24

1.25

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

150

1.07

0.04

3.0

1.5

—

(3022313) Gas panel - Capillary blood

119

0.92

0.04

7.9

5.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

622

0.98

0.03

5.3

4.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

231

1.04

0.03

3.5

4.3

31.78

31.90

—

161

(3047352) Trisomy 18 risk [Likelihood] in Fetus

132

1.06

0.02

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

177

1759

1.02

0.02

3.9

3.5

38.51

44.34

u/l

0.80

166

1698

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

969

0.99

0.01

1.7

1.9

1.72

1.40

mmol/l

1.20

843

(3016502) Oxygen saturation in Arterial blood

177

0.96

0.01

6.7

9.6

96.72

95.58

0.57

172

(3010813) Leukocytes [#/volume] in Blood

260

2598

1.02

0.00

23.5

20.6

6.89

6.77

e9/l

0.44

253

2550

(3008898) HLA-B27 [Presence]

138

1.02

0.00

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

260

2599

1.01

0.00

23.6

20.6

136.50

137.39

g/l

0.45

260

2581

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

101

0.99

0.00

1.8

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

521

1.00

0.00

2.5

3.7

23.36

22.23

0.18

198

(3026361) Erythrocytes [#/volume] in Blood

260

2597

1.03

0.00

23.4

20.5

4.56

4.58

e12/l

0.31

255

2551

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

260

2597

1.03

0.00

23.7

20.9

40.96

40.95

0.01

260

2576

(3035941) MCH [Entitic mass]

260

2597

1.03

0.00

23.4

20.4

30.12

30.18

0.20

260

2578

(3007461) Platelets [#/volume] in Blood

260

2595

1.05

0.00

23.4

20.5

256.21

255.80

e9/l

0.04

254

2556

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

157

1.02

0.00

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

167

1.02

0.00

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

646

1.01

0.00

3.5

4.0

1.49

1.59

ug/l

0.15

589

(3024731) MCV [Entitic mean volume] in Red Blood Cells

260

2596

1.04

0.00

23.4

20.5

90.18

90.19

0.01

260

2578

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

3.74

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

0.92

0.00

1.2

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.1

—

4.54

—

(3017704) Immunofixation for Urine

0.00

0.0

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.1

—

10.40

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(4133840) Spirometry

0.00

0.0

1.0

—

(3048879) Bone marrow aspiration report

0.00

-0.00

0.0

3.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

-0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(3013727) Leukocytes other/Leukocytes in Blood

0.00

-0.00

0.0

3.5

—

55.92

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.87

-0.00

1.2

1.6

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.6

—

3.29

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

79.14

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

6.0

—

6.32

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

6.0

—

4.80

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

8.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

2.6

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1.01

-0.00

1.6

1.7

1.03

1.40

g/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

-0.00

0.0

1.6

—

60.22

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

2.02

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

2.3

—

44.33

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

10.96

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.94

-0.00

1.4

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

0.95

-0.00

1.7

1.5

1398.83

121.47

e6/l

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.1

—

7.43

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.89

-0.00

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.8

—

5.92

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.94

-0.00

1.0

1.3

—

95.00

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

9.62

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

64.00

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.97

-0.00

1.1

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.94

-0.00

1.4

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

0.97

-0.00

1.7

1.4

23.17

13.06

e6/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

-0.00

0.0

1.1

—

148.51

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_PEDICULOSIS_AND_PHTHIRIAASIS_WIDE – Pediculosis and phthiriasis, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Pediculosis and phthiriasis, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Pediculosis and phthiriasis, including avohilmo (AB1_PEDICULOSIS_AND_PHTHIRIAASIS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints